Rocket Pharmaceuticals (RCKT) Research & Development: 2016-2025
Historic Research & Development for Rocket Pharmaceuticals (RCKT) over the last 10 years, with Sep 2025 value amounting to $34.1 million.
- Rocket Pharmaceuticals' Research & Development fell 19.49% to $34.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $150.0 million, marking a year-over-year decrease of 14.58%. This contributed to the annual value of $171.2 million for FY2024, which is 8.10% down from last year.
- Rocket Pharmaceuticals' Research & Development amounted to $34.1 million in Q3 2025, which was down 20.14% from $42.7 million recorded in Q2 2025.
- In the past 5 years, Rocket Pharmaceuticals' Research & Development registered a high of $51.4 million during Q2 2023, and its lowest value of $24.5 million during Q2 2021.
- Over the past 3 years, Rocket Pharmaceuticals' median Research & Development value was $42.7 million (recorded in 2025), while the average stood at $42.8 million.
- Examining YoY changes over the last 5 years, Rocket Pharmaceuticals' Research & Development showed a top increase of 82.95% in 2021 and a maximum decrease of 34.09% in 2021.
- Over the past 5 years, Rocket Pharmaceuticals' Research & Development (Quarterly) stood at $33.0 million in 2021, then soared by 51.55% to $50.0 million in 2022, then decreased by 16.57% to $41.7 million in 2023, then declined by 10.51% to $37.4 million in 2024, then decreased by 19.49% to $34.1 million in 2025.
- Its last three reported values are $34.1 million in Q3 2025, $42.7 million for Q2 2025, and $35.9 million during Q1 2025.